カテゴリー： 世界, 医療/バイオ, Grand View Research

世界のプロテイナーゼK市場（2023-2030）：形態別（粉末、液体）、治療領域別（感染症、神経、腫瘍、循環器）、用途別、エンドユーザー別、地域別

【英語タイトル】Proteinase K Market Size, Share & Trends Analysis Report By Form (Powder, Liquid), By Therapeutic Area (Infectious Diseases, Neurology, Oncology, Cardiology), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NOV182）・商品コード：GRV23NOV182
・発行会社（調査会社）：Grand View Research
・発行日：2023年9月
・ページ数：150
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：臨床診断
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

プロテイナーゼK市場の成長と動向
Grand View Research, Inc.の最新レポートによると、プロテイナーゼKの世界市場規模は2030年までに78億米ドルに達し、予測期間中のCAGRは8.7%を記録する見込みです。市場成長の原動力となっているのは、分子診断技術とそれに関連する体外診断用酵素における幅広い用途です。プロテイナーゼKはPCRやNGSの補助酵素として利用できます。遺伝子発現プロファイリングとqPCRによる標的パネルは、病理検査室におけるNGSシーケンスの最も頻繁な用途の2つです。さらに、NGSシーケンスの価格低下により、NSC技術の利用が拡大しています。したがって、NGS診断技術に対する需要の高まりは、市場の成長を後押しすると予想されます。

さらに、細胞分離手順の採用が増加していることも、市場成長に寄与する主な要因の1つです。企業は市場での競争力を獲得するため、持続可能な技術の構築に着手しています。例えば、2022年4月、Levitas Bio社は、既存の細胞分離用プラットフォームの次世代版を発表しました。この新バージョンは、研究者の実験を最大16倍まで拡大し、1回あたり約4000万個の細胞を処理できるようになる見込みです。

さらに、POCベースの診断薬の使用は世界的に大幅に増加しています。感染症の症状やその予防法を特定することを目的とした一般市民の意識向上キャンペーンは、病気の伝播をコントロールする上で重要な役割を果たしています。このように、患者の関心の高まりがPOCの需要増につながっています。例えば、2020年5月には、Specific High Sensitivity Enzymatic Reporter UnLOCKing（SHERLOCK）診断法によるCOVID-19のPOC検査に関する研究が発表されました。このように、POC診断に対する需要の高まりと、POC診断検査におけるプロテイナーゼKの有用性は、市場の成長を促進すると予想されます。

さらに、分子生物学やその他の分野でのプロテイナーゼKの用途の拡大は、近い将来に有利な機会を生み出すと期待されています。プロテイナーゼKは、食品・飲料業界で品質基準を維持するために使用されています。食品メーカーは、製造に使用する原材料の品質維持に努めています。さらに、プロテイナーゼKは加工食品からDNAを抽出する際の細胞溶解にも使用されます。この酵素は、分子生物学的アッセイにも幅広く応用されています。したがって、プロテイナーゼKのこのような用途は、予測期間中に市場を牽引すると予想されます。

プロテイナーゼK市場レポートハイライト

- 形態別では、粉末セグメントが2022年に圧倒的なシェアを占めました。粉末の利点は、保存期間が長いこと、安価に出荷できること、安定性が高いことなどです。このような利点により、粉末の採用が増加すると予測されます。

- 治療領域別では、感染症領域が2022年に最大シェアを獲得しました。低・中所得国での感染症罹患率の増加とともに、迅速分子検査におけるプロテイナーゼKの存在が、低資源環境での運用が容易な製品の開発を促進すると予想されます。これが市場の成長を加速させています。

- 用途別では、ゲノムDNAおよびRNAの分離・精製分野が2022年に最大シェアを獲得しました。がんや希少疾患における個別化治療のニーズが高まる中、DNAやRNAの単離に対する需要は増加傾向にあり、同様の傾向は市場にも反映されると予想されます。

- 最終用途別では、バイオテクノロジー企業が2022年に主要な収益シェアを占めました。これは、バイオテクノロジー企業の臨床および前臨床研究をサポートするためのインサイチュハイブリダイゼーション（ISH）技術のアプリケーションの増加によるものです。

- 北米は2022年に最大の市場シェアを占め、同地域におけるプロテイナーゼKの高い需要と感染症の蔓延の増加により、予測期間中もリードを維持する見込みです。

- アジア太平洋地域は、ゲノミクス研究を促進するための政府の様々な取り組みとシーケンス技術のアプリケーションの増加により、将来的に大きく成長すると予測されています。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 市場変動・動向・範囲
第4章. 世界のプロテイナーゼK市場：形態別予測・動向分析
第5章. 世界のプロテイナーゼK市場：治療領域別予測・動向分析
第6章. 世界のプロテイナーゼK市場：エンドユーザー別予測・動向分析
第7章. 世界のプロテイナーゼK市場：用途別予測・動向分析
第8章. 世界のプロテイナーゼK市場：地域別予測・動向分析
第9章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Form
1.1.2. Therapeutic area
1.1.3. End use
1.1.4. Application
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Form outlook
2.2.2. Therapeutic area outlook
2.2.3. End use outlook
2.2.4. Application outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Proteinase K Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Proteinase K Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Proteinase K: Form Estimates & Trend Analysis
4.1. Proteinase K Market: Key Takeaways
4.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Powder
4.3.1. Powder market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Liquid
4.4.1. Liquid market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Proteinase K: Therapeutic Area Estimates & Trend Analysis
5.1. Proteinase K Market: Key Takeaways
5.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Infectious Diseases
5.3.1. Infectious diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Diabetes
5.4.1. Diabetes market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. Oncology
5.5.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Cardiology
5.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Nephrology
5.7.1. Nephrology market estimates and forecasts, 2018 to 2030 (USD Million)
5.8. Autoimmune Diseases
5.8.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
5.9. Neurology
5.9.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
5.10. Others
5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Proteinase K: End Use Estimates & Trend Analysis
6.1. Proteinase K Market: Key Takeaways
6.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
6.3. Isolation and Purification of Genomic DNA & RNA
6.3.1. Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. In Situ Hybridization
6.4.1. In situ hybridization market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Mitochondria Isolation
6.5.1. Mitochondria isolation market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Proteinase K: Application Estimates & Trend Analysis
7.1. Proteinase K Market: Key Takeaways
7.2. Proteinase K Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Contract Research Organization
7.3.1. Contract research organization market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Academic Institutes
7.4.1. Academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Biotechnology Companies
7.5.1. Biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
7.6. Diagnostic Laboratories
7.6.1. Diagnostic laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Proteinase K Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Proteinase K Market by Region: Key Takeaways
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Denmark
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Sweden
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Norway
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. South Africa
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. Saudi Arabia
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. Merck KGaA
9.2.1.1. Company overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic initiatives
9.2.2. QIAGEN
9.2.2.1. Company overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Thermo Fisher Scientific, Inc.
9.2.3.1. Company overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic initiatives
9.2.4. F. Hoffmann-La Roche Ltd
9.2.4.1. Company overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic initiatives
9.2.5. Abcam plc.
9.2.5.1. Company overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic initiatives
9.2.6. Agilent Technologies, Inc.
9.2.6.1. Company overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Biocatalysts
9.2.7.1. Company overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Minerva Biolabs GmbH
9.2.8.1. Company overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Promega Corporation
9.2.9.1. Company overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Takara Bio Inc.
9.2.10.1. Company overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
9.2.11. New England Biolabs
9.2.11.1. Company overview
9.2.11.2. Financial performance
9.2.11.3. Product benchmarking
9.2.11.4. Strategic initiatives
9.2.12. MP BIOMEDICALS.
9.2.12.1. Company overview
9.2.12.2. Financial performance
9.2.12.3. Product benchmarking
9.2.12.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviation
Table 2 North America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 3 North America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 North America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 5 North America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 6 North America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 7 U.S. proteinase K market, by form, 2018 - 2030 (USD Million)
Table 8 U.S. proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 9 U.S. proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 10 U.S. proteinase K market, by application, 2018 - 2030 (USD Million)
Table 11 Canada proteinase K market, by form, 2018 - 2030 (USD Million)
Table 12 Canada proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 13 Canada proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 14 Canada proteinase K market, by application, 2018 - 2030 (USD Million)
Table 15 Europe proteinase K market, by form, 2018 - 2030 (USD Million)
Table 16 Europe proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 17 Europe proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 18 Europe proteinase K market, by application, 2018 - 2030 (USD Million)
Table 19 Europe proteinase K market, by region, 2018 - 2030 (USD Million)
Table 20 UK proteinase K market, by form, 2018 - 2030 (USD Million)
Table 21 UK proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 22 UK proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 23 UK proteinase K market, by application, 2018 - 2030 (USD Million)
Table 24 Germany proteinase K market, by form, 2018 - 2030 (USD Million)
Table 25 Germany proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 26 Germany proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 27 Germany proteinase K market, by application, 2018 - 2030 (USD Million)
Table 28 France proteinase K market, by form, 2018 - 2030 (USD Million)
Table 29 France proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 30 France proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 31 France proteinase K market, by application, 2018 - 2030 (USD Million)
Table 32 Italy proteinase K market, by form, 2018 - 2030 (USD Million)
Table 33 Italy proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 34 Italy proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 35 Italy proteinase K market, by application, 2018 - 2030 (USD Million)
Table 36 Spain proteinase K market, by form, 2018 - 2030 (USD Million)
Table 37 Spain proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 38 Spain proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 39 Spain proteinase K market, by application, 2018 - 2030 (USD Million)
Table 40 Denmark proteinase K market, by form, 2018 - 2030 (USD Million)
Table 41 Denmark proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 42 Denmark proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 43 Denmark proteinase K market, by application, 2018 - 2030 (USD Million)
Table 44 Sweden proteinase K market, by form, 2018 - 2030 (USD Million)
Table 45 Sweden proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 46 Sweden proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 47 Sweden proteinase K market, by application, 2018 - 2030 (USD Million)
Table 48 Norway proteinase K market, by form, 2018 - 2030 (USD Million)
Table 49 Norway proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 50 Norway proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 51 Norway proteinase K market, by application, 2018 - 2030 (USD Million)
Table 52 Asia Pacific proteinase K market, by form, 2018 - 2030 (USD Million)
Table 53 Asia Pacific proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 54 Asia Pacific proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 55 Asia Pacific proteinase K market, by application, 2018 - 2030 (USD Million)
Table 56 Asia Pacific proteinase K market, by region, 2018 - 2030 (USD Million)
Table 57 Japan proteinase K market, by form, 2018 - 2030 (USD Million)
Table 58 Japan proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 59 Japan proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 60 Japan proteinase K market, by application, 2018 - 2030 (USD Million)
Table 61 China proteinase K market, by form, 2018 - 2030 (USD Million)
Table 62 China proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 63 China proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 64 China proteinase K market, by application, 2018 - 2030 (USD Million)
Table 65 India proteinase K market, by form, 2018 - 2030 (USD Million)
Table 66 India proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 67 India proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 68 India proteinase K market, by application, 2018 - 2030 (USD Million)
Table 69 Australia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 70 Australia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 71 Australia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 72 Australia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 73 Thailand proteinase K market, by form, 2018 - 2030 (USD Million)
Table 74 Thailand proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 75 Thailand proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 76 Thailand proteinase K market, by application, 2018 - 2030 (USD Million)
Table 77 South Korea proteinase K market, by form, 2018 - 2030 (USD Million)
Table 78 South Korea proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 79 South Korea proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 80 South Korea proteinase K market, by application, 2018 - 2030 (USD Million)
Table 81 Latin America proteinase K market, by form, 2018 - 2030 (USD Million)
Table 82 Latin America proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 83 Latin America proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 84 Latin America proteinase K market, by application, 2018 - 2030 (USD Million)
Table 85 Latin America proteinase K market, by region, 2018 - 2030 (USD Million)
Table 86 Brazil proteinase K market, by form, 2018 - 2030 (USD Million)
Table 87 Brazil proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 88 Brazil proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 89 Brazil proteinase K market, by application, 2018 - 2030 (USD Million)
Table 90 Mexico proteinase K market, by form, 2018 - 2030 (USD Million)
Table 91 Mexico proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 92 Mexico proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 93 Mexico proteinase K market, by application, 2018 - 2030 (USD Million)
Table 94 Argentina proteinase K market, by form, 2018 - 2030 (USD Million)
Table 95 Argentina proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 96 Argentina proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 97 Argentina proteinase K market, by application, 2018 - 2030 (USD Million)
Table 98 Middle East and Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 99 Middle East and Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 100 Middle East and Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 101 Middle East and Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 102 Middle East and Africa proteinase K market, by region, 2018 - 2030 (USD Million)
Table 103 South Africa proteinase K market, by form, 2018 - 2030 (USD Million)
Table 104 South Africa proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 105 South Africa proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 106 South Africa proteinase K market, by application, 2018 - 2030 (USD Million)
Table 107 Saudi Arabia proteinase K market, by form, 2018 - 2030 (USD Million)
Table 108 Saudi Arabia proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 109 Saudi Arabia proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 110 Saudi Arabia proteinase K market, by application, 2018 - 2030 (USD Million)
Table 111 UAE proteinase K market, by form, 2018 - 2030 (USD Million)
Table 112 UAE proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 113 UAE proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 114 UAE proteinase K market, by application, 2018 - 2030 (USD Million)
Table 115 Kuwait proteinase K market, by form, 2018 - 2030 (USD Million)
Table 116 Kuwait proteinase K market, by therapeutic area, 2018 - 2030 (USD Million)
Table 117 Kuwait proteinase K market, by end use, 2018 - 2030 (USD Million)
Table 118 Kuwait proteinase K market, by application, 2018 - 2030 (USD Million) 

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Proteinase K: Market outlook
Fig. 9 Proteinase K: Competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Proteinase K market driver impact
Fig. 15 Proteinase K market restraint impact
Fig. 16 Proteinase K market strategic initiatives analysis
Fig. 17 Proteinase K market: Form movement analysis
Fig. 18 Proteinase K market: Form outlook and key takeaways
Fig. 19 Powder market estimates and forecasts, 2018 - 2030
Fig. 20 Liquid market estimates and forecasts, 2018 - 2030
Fig. 21 Proteinase K market: Therapeutic area movement analysis
Fig. 22 Proteinase K market: Therapeutic area outlook and key takeaways
Fig. 23 Infectious diseases market estimates and forecasts, 2018 - 2030
Fig. 24 Diabetes market estimates and forecasts, 2018 - 2030
Fig. 25 Oncology market estimates and forecasts, 2018 – 2030
Fig. 26 Cardiology market estimates and forecasts, 2018 - 2030
Fig. 27 Nephrology market estimates and forecasts, 2018 - 2030
Fig. 28 Autoimmune diseases market estimates and forecasts, 2018 - 2030
Fig. 29 Neurology market estimates and forecasts, 2018 - 2030
Fig. 30 Others market estimates and forecasts, 2018 - 2030
Fig. 31 Proteinase K market: Application movement analysis
Fig. 32 Proteinase K market: Application outlook and key takeaways
Fig. 33 Isolation and purification of genomic DNA & RNA market estimates and forecasts, 2018 - 2030
Fig. 34 In situ hybridization market estimates and forecasts, 2018 - 2030
Fig. 35 Mitochondria isolation market estimates and forecasts, 2018 – 2030
Fig. 36 Proteinase K market: End use movement analysis
Fig. 37 Proteinase K market: End use outlook and key takeaways
Fig. 38 Contract research organization market estimates and forecasts, 2018 - 2030
Fig. 39 Academic institutes market estimates and forecasts, 2018 - 2030
Fig. 40 Biotechnology companies market estimates and forecasts, 2018 - 2030
Fig. 41 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
Fig. 42 Global proteinase K market: Regional movement analysis
Fig. 43 Global proteinase K market: Regional outlook and key takeaways
Fig. 44 North America market estimates and forecasts, 2018 - 2030
Fig. 45 U.S. market estimates and forecasts, 2018 - 2030
Fig. 46 Canada market estimates and forecasts, 2018 - 2030
Fig. 47 Europe market estimates and forecasts, 2018 - 2030
Fig. 48 UK market estimates and forecasts, 2018 - 2030
Fig. 49 Germany market estimates and forecasts, 2018 - 2030
Fig. 50 France market estimates and forecasts, 2018 - 2030
Fig. 51 Italy market estimates and forecasts, 2018 - 2030
Fig. 52 Spain market estimates and forecasts, 2018 - 2030
Fig. 53 Denmark market estimates and forecasts, 2018 - 2030
Fig. 54 Sweden market estimates and forecasts, 2018 - 2030
Fig. 55 Norway market estimates and forecasts, 2018 - 2030
Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030
Fig. 57 Japan market estimates and forecasts, 2018 - 2030
Fig. 58 China market estimates and forecasts, 2018 - 2030
Fig. 59 India market estimates and forecasts, 2018 - 2030
Fig. 60 Australia market estimates and forecasts, 2018 - 2030
Fig. 61 Thailand market estimates and forecasts, 2018 - 2030
Fig. 62 South Korea market estimates and forecasts, 2018 - 2030
Fig. 63 Latin America market estimates and forecasts, 2018 - 2030
Fig. 64 Brazil market estimates and forecasts, 2018 - 2030
Fig. 65 Mexico market estimates and forecasts, 2018 - 2030
Fig. 66 Argentina market estimates and forecasts, 2018 - 2030
Fig. 67 Middle East and Africa. market estimates and forecasts, 2018 - 2030
Fig. 68 South Africa market estimates and forecasts, 2018 - 2030
Fig. 69 Saudi Arabia market estimates and forecasts, 2018 - 2030
Fig. 70 UAE market estimates and forecasts, 2018 - 2030
Fig. 71 Kuwait market estimates and forecasts, 2018 - 2030

★調査レポート[世界のプロテイナーゼK市場（2023-2030）：形態別（粉末、液体）、治療領域別（感染症、神経、腫瘍、循環器）、用途別、エンドユーザー別、地域別] (コード：GRV23NOV182)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のプロテイナーゼK市場（2023-2030）：形態別（粉末、液体）、治療領域別（感染症、神経、腫瘍、循環器）、用途別、エンドユーザー別、地域別]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のファーマコゲノミクス技術市場（2023-2030）：治療領域別、技術別（PCR、インサイチュハイブリダイゼーション、免疫組織化学、シークエンシング、その他）、地域別
  • 世界の抗体受託開発・製造機関市場2023-2030：製品別、供給源別、治療領域別（腫瘍学、神経学、心臓病学）、エンドユーザー別、地域別
  • 世界の超音波ジェル市場（2023-2030）：種類別（非滅菌、滅菌）、エンドユーザー別（病院、外来センター、クリニック）、地域別
  • 世界のレジオネラ菌検査市場（2023-2030）：種類別（水質検査、IVD検査）、エンドユーザー別（微生物培養、直接蛍光抗体（DFA）染色、PCR、その他）、地域別
  • 世界の医療用カート市場（2023-2030）：製品別（移動型コンピューティングカート、壁掛け型ワークステーション、薬剤）、種類別（麻酔、救急、処置）、エンドユーザー別、地域別
  • 世界の非侵襲的脂肪減少市場（2023-2030）：技術別（クライオリポライシス、超音波）、エンドユーザー別（病院、単独診療所、多科目クリニック）、地域別
  • 世界の呼吸器疾患検査市場（2023-2030）：製品別（画像検査、呼吸計、血液ガス検査）、エンドユーザー別、用途別、地域別
  • 世界の子宮マニピュレーション機器市場（2023-2030）：用途別（腹腔鏡下子宮全摘出術、腹腔鏡下子宮頸部上全摘出術）、エンドユーザー別（病院、クリニック、ASC）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆